Pathologist reviewed and approved · 29 September 2026

Hematology workflow guide · Reviewed

Manual Differential Cell Counting: A Practical Hematology Workflow

A practical guide to smear selection, systematic cell classification, count recording, percentages, documentation, and the limits of digital counters.

Direct answer

A manual differential count is a structured review of stained blood or marrow material. A trained observer selects representative areas, classifies each eligible cell, records the categories against a defined total, and documents the resulting proportions and relevant morphology. The counting tool records choices; it does not decide what a cell is. Specimen quality, local protocols, and professional interpretation still determine whether the result is reliable.

Key takeaways

  • Choose representative, well-preserved material before starting the tally.
  • Use a consistent field progression and record the actual number of cells assessed.
  • A digital counter supports recording; cell identification and interpretation remain professional tasks.
A count is a sequence, not just a number

Conceptual workflow only; the local laboratory procedure governs the actual method.

What a manual differential contributes

A manual count places cell categories in the context of a directly observed smear. Microscopy may be required when analyzer results or flags meet a laboratory’s validated review criteria; a count and a broader morphology review are related but distinct tasks. [1] [2]

The 2026 peripheral-smear implementation paper discusses system, suspect, and numerical flags and delta checks as possible review triggers, and emphasizes local validation and institution-specific workflow. [3]

For peripheral blood, the observer usually records leukocyte categories. A marrow nucleated differential also considers maturation across several lineages and abnormal populations. The eligible denominator and reporting rules must follow the specimen type and local protocol.

A practical workflow

For example, 17 cells in a category among 100 assessed represent 17%; 17 among 200 represent 8.5%. The denominator must be the number actually counted, even when a target was selected in advance.

In one microscopy sequence described by the founder, he uses the 4× scanning objective to survey the smear head, body, and tail in a zig-zag overview. At 10× he assesses overall cell distribution, smear quality, and platelet clumping. At 40× he makes a preliminary RBC and platelet assessment, then uses oil immersion at 100× for the WBC differential and detailed RBC, platelet, and other relevant morphological review. Hemoparasites are assessed when clinically relevant. This is a founder-practice example, not a universal mandatory sequence; local procedures and clinical context govern.

  1. Confirm case identity, specimen type, clinical context available to the reviewer, and the applicable laboratory procedure.
  2. Inspect the preparation and staining. Choose representative, well-preserved areas rather than the first convenient field.
  3. Move through fields systematically so that cells are neither favored nor counted twice.
  4. Identify each eligible cell using the laboratory’s classification rules and enter one category per observed cell.
  5. Pause for uncertain or abnormal cells; record a question or seek the required review rather than guessing.
  6. Reconcile the category tallies with the actual total and calculate each category as count ÷ total × 100.
  7. Document specimen adequacy, total assessed, category proportions, important morphology observations, and any limits.

Errors to watch for

Consistency in morphology terms and reporting matters; the ICSH provides consensus nomenclature for peripheral blood cell abnormalities. [1]

From the founder’s practical experience, a second review may help when morphology is difficult to classify or when the category could materially change the reported differential. Examples he identified include blasts or other immature cells in which lineage or exact classification is uncertain, promyelocyte versus myelocyte, reactive lymphocyte versus atypical or immature lymphoid morphology, and unusual cells that do not fit a clear morphological category. These are examples, not a universal mandatory second-review checklist; follow the laboratory’s applicable review pathway. A second review alone does not establish lineage; ancillary testing may be needed depending on the diagnostic question.

  • Counting a visibly unrepresentative area or changing the field path opportunistically.
  • Using inconsistent category definitions, especially for borderline or abnormal cells.
  • Reporting a target count instead of the actual count achieved.
  • Treating a percentage as a complete morphology interpretation.

Where HemaSync fits

HemaSync provides manual count targets, category recording, case workflow, optional voice input, and optional AI-assisted interpretation. The observer identifies each cell and checks every entry. HemaSync does not inspect a smear, automatically classify a cell, or replace a pathologist or trained laboratory professional.

If AI-assisted hematology interpretation is used, it is intended to support review by qualified healthcare professionals and does not replace professional judgment.

References

  1. Palmer L, et al. ICSH recommendations for peripheral blood cell morphology nomenclature and grading. Int J Lab Hematol. 2015.
  2. Barnes PW, et al. International consensus criteria for action after automated CBC and differential analysis. Lab Hematol. 2005. Historical consensus background; not a universal current rule.
  3. Pozdnyakova O, Yaeger LH, Shirai CL, et al. Practical Considerations in the Implementation of Peripheral Smear Review in the Clinical Laboratory. Int J Lab Hematol. 2026;48(5):937-950. doi:10.1111/ijlh.70131.